Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
ORTHOPEDIATRICS CORP (KIDS)
|
Add to portfolio |
|
|
|
| Price: |
$57.66
| | Metrics |
| OS: |
23.0
|
M
| |
|
|
| Market cap: |
$1.33
|
B
| |
|
|
|
Net cash:
|
$108
|
M
| |
$4.69
|
per share
|
|
EV:
|
$1.22
|
B
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
|
| |
|
|
|
EBIT
|
|
| |
|
|
| EPS |
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-05-18 | Dec-31-17 | Dec-31-16 |
| Revenues | 122.3 | 98.0 | 71.1 | 72.6 | 57.6 | 57.6 | 45.6 | 37.3 |
| Revenue growth | 24.7% | 37.9% | -2.0% | 26.0% | 26.2% | | 22.3% | 20.3% |
| Cost of goods sold | 31.6 | 24.6 | 16.0 | 17.9 | 14.9 | 14.9 | 11.2 | 10.9 |
| Gross profit | 90.7 | 73.4 | 55.0 | 54.6 | 42.7 | 42.7 | 34.5 | 26.4 |
| Gross margin | 74.1% | 74.9% | 77.4% | 75.3% | 74.2% | 74.2% | 75.5% | 70.7% |
| Sales and marketing | 45.1 | 39.7 | 31.9 | 31.3 | 26.6 | 26.6 | 20.5 | 16.7 |
| Research and development | 8.0 | 5.5 | 5.3 | 5.7 | 4.7 | 4.7 | 3.4 | 2.2 |
| General and administrative | 59.4 | 46.1 | 38.3 | 26.7 | 20.9 | 20.9 | 17.0 | 11.6 |
| EBITA | -15.8 | -13.5 | -23.5 | -8.2 | -9.2 | -9.6 | -6.2 | -6.1 |
| EBITA margin | -12.9% | -13.8% | -33.1% | -11.3% | -15.9% | -16.6% | -13.6% | -16.3% |
| Amortization of intangibles | 6.0 | 4.5 | 3.2 | 0.9 | 0.4 | | 0.2 | 0.0 |
| EBIT | -21.8 | -18.0 | -26.8 | -9.1 | -9.6 | -9.6 | -6.5 | -6.1 |
| EBIT margin | -17.8% | -18.4% | -37.6% | -12.5% | -16.6% | -16.6% | -14.2% | -16.4% |
| Pre-tax income | -3.7 | -17.4 | -33.7 | -12.7 | -12.0 | -12.0 | -9.0 | -6.6 |
| Income taxes | -4.9 | -1.1 | -0.7 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | 134.1% | 6.5% | 2.1% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | 1.3 | -16.3 | -32.9 | -12.7 | -12.0 | -12.0 | -23.5 | -12.4 |
| Net margin | 1.0% | -16.6% | -46.3% | -17.5% | -20.9% | -20.9% | -51.6% | -33.4% |
| |
| Diluted EPS | $0.06 | ($0.84) | ($1.82) | ($0.87) | ($0.96) | ($0.96) | ($5.86) | ($7.14) |
| Shares outstanding (diluted) | 20.9 | 19.3 | 18.1 | 14.6 | 12.6 | 12.6 | 4.0 | 1.7 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|